The global gastrointestinal stent market holds a valuation of US$ 455.44 Million by the end of the year 2022. Throughout the forecast period of 2023 to 2033, the market is likely to display growth at a CAGR of 5.5%, and is expected to hold a market value of around US$ 815.34 Million in 2033.
Market Outlook:
| Data Points | Market Insights |
|---|---|
| Market Value 2022 | US$ 455.44 Million |
| Market Value 2023 | US$ 476.72 Million |
| Market Value 2033 | US$ 815.34 Million |
| CAGR 2023 to 2033 | 5.51% |
| Market Share of Top 5 Countries | 65.3% |
| Key Market Players | Boston Scientific Corporation, Hobbs Medical Inc., Taewoong Medical, Micro–Tech (Nanjing) Co., Ltd., Olympus Corporation, Merit Medical Systems, Qualimed, Medtronic, Conmed Corporation, Terumo Corporation, Johnson & Johnson Services, Inc., 3M, Smith & Nephew, Diagmed Healthcare, Medline Industries, Inc., Baxter, B. Braun Melsungen AG, Danaher Corporation, General Electric Company, Cantel Medical Corporation, ConvaTec Inc., and M.C. Johnson Company, Inc. |
An artificial tube graft called gastrointestinal (GI) stent is put into the body to prevent obstructions in the stomach, oesophagus, and small intestine. It is an expandable metal or plastic mesh tube that is inserted into an anatomical duct to treat blockages brought on by malignant tissues in the bile ducts, oesophagus, intestine, or colon. It helps to eliminate the blockage and reduce the pressure caused by inflammation. A few of the most prevalent types of gastrointestinal stents are biliary, colonic, duodenal, esophageal, and pancreatic stents.
One of the main factors fuelling the market's expansion is the increased incidence of colorectal cancer in the world and rising geriatric population with gastrointestinal conditions such as diverticulosis, bowel disorders, and gastrointestinal cancers.
As per the World Health Organization (WHO), in 2020, colorectal cancer caused more than 1.9 million new cases and more than 930,000 deaths worldwide. By 2040, there will be 3.2 million new occurrences of colorectal cancer annually (an increase of 63%) and 1.6 million annual fatalities (an increase of 73%).
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The gastrointestinal stent market expanded at a CAGR of 3.8% between 2017 and 2022 period due to numerous medical advancements and studies to upgrade diagnostic technologies, as well as the rise in demand for less invasive surgical treatments.
The global gastrointestinal stent contributed around 4.3% revenue share to the US$ 10.5 Billion gastrointestinal devices market in 2022.
Gastrointestinal stents are made to provide palliative care for a variety of illnesses that obstruct the GI tract. In the recanalization of gastrointestinal tumors and postoperative leak sealing, GI stents play a significant role. Drug–eluting devices, tissue modelling for benign conditions, and GI tract drainage/anastomosis are some additional potential uses for GI stents. The market for gastrointestinal stents is attributed to changing lifestyles and the rising incidence of GI cancers and other digestive diseases.
The stent manufacturers are also focusing on product development with the use of smart phone application and more market penetration for the product. Other factors expected to drive market growth include the implementation of advantageous government policies, significant expansion of healthcare infrastructure, and extensive research and development efforts, and increased focus by diagnostic laboratories on adoption of advanced technologies.
The increasing prevalence of cancer, growing demand for minimally invasive surgical procedures, development of advanced diagnostic technologies and rising disposable income, all these factors promotes the growth of global market over the forecast period.
| Market Statistics | Details |
|---|---|
| Jan to Jun (H1), 2021 (A) | 3.29% |
| Jul to Dec (H2), 2021 (A) | 4.71% |
| Jan to Jun (H1),2022 Projected (P) | 3.47% |
| Jan to Jun (H1),2022 Outlook (O) | 3.73% |
| Jul to Dec (H2), 2022 Outlook (O) | 4.81% |
| Jul to Dec (H2), 2022 Projected (P) | 4.46% |
| Jan to Jun (H1), 2023 Projected (P) | 4.25% |
| BPS Change : H1,2022 (O) - H1,2022 (P) | 25 ↑ |
| BPS Change : H1,2022 (O) - H1,2021 (A) | 44 ↑ |
| BPS Change: H2, 2022 (O) - H2, 2022 (P) | 35 ↑ |
| BPS Change: H2, 2022 (O) - H2, 2022 (A) | 10 ↑ |
Principal Consultant
One of the biggest causes of death around the globe is gastrointestinal cancer. Morbidity and mortality from chronic diseases like esophageal cancer, colorectal cancer, gastrointestinal digestive disorders, etc., have sharply increased in recent years.
According to statistics on cancer published in the International Journal of Cancer 2020, stomach cancer accounted for about 1.1 million new cases worldwide in 2020 and was the fourth leading cause of cancer death, accounting for about 800,000 deaths. It was also the fifth most common malignant tumor worldwide.
Companies have been manufacturing products like biodegradable stents made of biodegradable materials like polyester, polycarbonate, bacterially produced polymers etc. with the potential to elute drugs. Drug–stents can reduce lumen occlusion rates by delivering targeted drugs directly to tissue in addition to radial expansion to maintain luminal potency. As they progressively break down and are finally absorbed from the GI, biodegradable stents also aid in preserving the digestive tract's functionality for a certain period. Above factors are expected to boost market growth and provide lucrative opportunities to the players globally.
Medical device approval regulations that are too strict will impede the market's expansion. The market growth rate will be further slowed down by unfavourable reimbursement circumstances in developing and underdeveloped economies along with stent–related complications. Biliary stents, as an example, exhibit early problems such as bleeding, infection, and pancreatitis. Esophageal stent therapy can cause painful foreign body symptoms and pulmonary aspiration as side effects.
The cost of healthcare has risen dramatically over the world in recent years, as have the prices of medical equipment. Healthcare providers and payers have limited financial means to spend on such a pricey surgery in developing nations like India and Brazil. In addition, Government in many Asian nations does not provide the healthcare coverage for endoscopic stenting treatments, which is one of the key reasons for patient and physician resistance to gastrointestinal stents. The absence of reimbursement in developing countries like India together with high product cost are expected to hinder the market growth in future.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Country | The USA |
|---|---|
| Market Share (2023) | 41.9% |
| Market Share (2033) | 43.7% |
| BPS Analysis | 180 |
| Country | Germany |
|---|---|
| Market Share (2023) | 7.5% |
| Market Share (2033) | 8.2% |
| BPS Analysis | 66 |
| Country | The United Kingdom |
|---|---|
| Market Share (2023) | 6.2% |
| Market Share (2033) | 5.8% |
| BPS Analysis | –42 |
| Country | China |
|---|---|
| Market Share (2023) | 4.7% |
| Market Share (2033) | 4.5% |
| BPS Analysis | –26 |
| Country | France |
|---|---|
| Market Share (2023) | 4.7% |
| Market Share (2033) | 4.4% |
| BPS Analysis | –25 |
The USA will dominate the global market in 2023 with a market share of 41.9%.
Presence of large number of players, increasing cases of cancer, advantageous medical reimbursement policies, advanced levels of healthcare technologies, greater adoption of minimally invasive surgeries have made the U.S. market to dominate globally.
According to data from the American Cancer Society, nearly 43,030 new cases of rectal cancer and around 97,220 new cases of colon cancer were reported in 2018, and the number of cases have been increasing.
Germany is set to hold a market share of 7.5% in 2023 within the global market.
In recent years, the role of stenting in the management of patients with digestive tract obstruction in Germany has expanded to include the oesophagus, stomach, small bowel, and colon. Recent technological advancements have improved stent patency and reduced stent–induced complications, resulting in a higher quality of life.
To avoid migration, a new device called Stentfix OTSC System has been developed in 2020. It is made up of a Nitinol clip that is preloaded on the applicator cap and is used to clip the flared end of FCSEMS (Fully Covered Self Expanding Metal Stent) to the gastrointestinal mucosal layer. Germany also has a large accessible medical facility, both of which are expected to increase demand for stents in the market.
The China market is set to hold around 4.7% revenue share in 2023 within the global market.
China market is increasing due to rising prevalence of gastrointestinal cancer and diseases. According to published report of 2022 in current oncology research article of MDPI publisher, reported upper gastrointestinal cancer incidences in China were 14,934,040 cases of male and 6,262,431 cases of female with growth rate 181.44% in between 1990 to 2019.
Another factor is the ongoing development of GI stents for various applications in order to expand treatment options and reduce complications.
Biliary stent product sale will exhibit 43.5% of the global market share in 2023.
One of the main factors driving the growth of the biliary stents market is the rising prevalence of bile duct cancer, chronic liver disease, rising gallstones patients, technological advancement for devices, increasing geriatric population, and various surgical procedure to cure biliary diseases.
Within the material category, self–expanding metal stent are expected to lead the global market with the market share of around 65.7% in 2023.
Factors responsible for the growth of this segment include an increase in demand for self–expanding metal stents due to benefits such as ease of insertion, reduced risk of dislodgment or migration, and extended patience
The growing prevalence and occurrences of pancreatic cancers are responsible for the segment's growth with an expected market share of 27.6% in 2023 globally.
According to published report of the American Cancer Society's on pancreatic cancer statistics in 2023, 33,130 males and 30,920 females will be diagnosed with the disease in the USA Furthermore, pancreatic cancer accounts for about 3% of cancer cases and 7% of cancer–related deaths in the USA
Increasing the use of biodegradable stents for the treatment of pancreatic cancer, which results in good palliation for patients during their remaining life span with no serious risks or complications would drive market growth.
In 2023, hospitals and clinics will dominate the global market with 63.5%.
The large share of this segment can be attributed to a large number of percutaneous transhepatic cholangiography (PTC) and endoscopic retrograde cholangiopancreatography (ERCP) procedures performed in hospital settings for various disease symptoms, increased government initiatives to provide standard gastrointestinal disease treatment and durable reimbursement scenarios.
Gastrointestinal Stent Market:
| Attributes | Gastrointestinal Stent Market |
|---|---|
| CAGR (2023 to 2033) | 5.5% |
| Market Value (2023) | US$ 476.72 Million |
| Growth Factor | Increased GI operation expenditure, rising GI cancer, and other digestive diseases prevalence, and increased preferences for minimally invasive surgeries |
| Key Market Trend | Numerous medical advancements and studies to upgrade diagnostic technologies demand for less invasive surgical treatments. |
Bioabsorbable Stents Market:
| Attributes | Bioabsorbable Stents Market |
|---|---|
| CAGR (2023 to 2033) | 4.1% |
| Market Value (2023) | US$ 172.3 Million |
| Growth Factor | Rising prevalence of cardiovascular diseases and increased percutaneous coronary intervention procedures, and minimally invasive procedures |
| Key Trend | A 3D printing technology is gaining traction; it is increasingly being used in the development of stents. |
Gastrointestinal Rare Diseases Treatment Market:
| Attributes | Gastrointestinal Rare Diseases Treatment Market |
|---|---|
| CAGR (2023 to 2033) | 3.6% |
| Market Value (2023) | US$ 1.36 Billion |
| Growth Factor | Increasing awareness of gastrointestinal diseases, the development of various medications, and government initiatives |
| Key Trend | Technological advancements, rising research and development (R&D) expenditures for the development of novel medicines |
The gastrointestinal stent industry is moderately competitive, with several global and regional companies. The need for stents in gastrointestinal endoscopy increases as the prevalence of diseases connected with the gastrointestinal tract rises. As a result, most big corporations are adopting growth plans to reach out to emerging markets by new product launch.
Similarly, recent developments have been tracked by the team at Future Market Insights related to companies in the gastrointestinal stent market, which are available in the full report.
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2017 to 2022 |
| Market Analysis | US$ Million for Value, and Units for Volume |
| Key Regions Covered | North America, Latin America, Europe, East Asia, South Asia, Oceania, Middle East and Africa (MEA) |
| Key Countries Covered | USA, Canada, Brazil, Mexico, Argentina, United Kingdom, Germany, Italy, France, Spain, Russia, BENELUX, China, Japan, South Korea, India, Indonesia, Malaysia, Thailand, Australia, New Zealand, GCC countries, Türkiye, South Africa and North Africa. |
| Key Market Segments Covered | Product, Material, Application, End User, and Region |
| Key Companies Profiled |
|
| Pricing | Available upon Request |
The growth potential of the gastrointestinal stent market is 5.5% through 2033.
The high cost of adoption is likely to limit market growth.
The United States is likely to capture a share of 43.7% by 2033.
The market in China will capture a share of 4.7% by 2033.
The United States, China, and the United Kingdom may witness significant growth in the market.
1. Executive Summary | Gastrointestinal Stent Market 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions and Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Market Innovation / Development Trends 4. Key Success Factors 4.1. Product Adoption/Usage Analysis 4.2. Key Promotional Strategies, by Manufacturers 4.3. Key Regulations 4.4. PESTEL Analysis 4.5. Porter’s Analysis 4.6. Disease Epidemiology 4.7. Product Launch Activities 4.8. Reimbursement Scenario 4.9. Value Chain Analysis 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global GDP Growth Outlook 5.1.2. Global Healthcare Outlook 5.1.3. Global Gastrointestinal Devices Market Overview 5.2. Forecast Factors - Relevance & Impact 5.2.1. Top Companies Historical Growth 5.2.2. New Product Launches and Approvals 5.2.3. Growing incidence of Gastrointestinal Epidemiology 5.2.4. R&D Expenditure by Key Players 5.2.5. Historic and Current Revenue of key players 5.2.6. Rising Consumer Awareness of the Product 5.2.7. Rising Adoption of Device Technological development 5.2.8. Strategic Developments by Key Players 5.2.9. Increase Adoption of Gastrointestinal Care & Cancer Care for Various Materials 5.2.10. Strategic Collaborations among Players 5.3. Market Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 6. COVID-19 Crisis Analysis 6.1. COVID-19 and Impact Analysis 6.1.1. By Product 6.1.2. By Material 6.1.3. By Application 6.1.4. By End User 6.1.5. By Country 6.2. 2022 Market Scenario 7. Global Market Volume (Units) Analysis 2017 to 2022 and Forecast, 2023 to 2033 7.1. Historical Market Volume (Units) Analysis, 2017 to 2022 7.2. Current and Future Market Volume (Units) Projections, 2023 to 2033 7.2.1. Y-o-Y Growth Trend Analysis 8. Global Market - Pricing Analysis 8.1. Regional Pricing Analysis By Material 8.2. Pricing Break-up 8.2.1. Manufacturer Level Pricing 8.2.2. Distributor Level Pricing 8.3. Global Average Pricing Analysis Benchmark 8.4. Pricing Assumptions 9. Global Market Demand (in Value or Size in US$ Million) Analysis 2017 to 2022 and Forecast, 2023 to 2033 9.1. Historical Market Value (US$ Million) and Volume (Units) Analysis, 2017 to 2022 9.2. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033 9.2.1. Y-o-Y Growth Trend Analysis 9.2.2. Absolute $ Opportunity Analysis 10. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Million) and Volume (Units) Analysis by Product, 2017 to 2022 10.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Product, 2023 to 2033 10.3.1. Biliary Stents 10.3.2. Duodenal Stents 10.3.3. Colonic Stents 10.3.4. Pancreatic Stents 10.3.5. Esophageal Stents 10.4. Market Attractiveness Analysis by Product 11. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Material 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Million) Analysis by Material, 2017 to 2022 11.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Material, 2023 to 2033 11.3.1. Self – Expanding Metal Stents 11.3.2. Plastic Stents 11.4. Market Attractiveness Analysis by Material 12. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Application 12.1. Introduction / Key Findings 12.2. Historical Market Size (US$ Million) Analysis by Application, 2017 to 2022 12.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Application, 2023 to 2033 12.3.1. Biliary Diseases 12.3.2. Irritable Bowel Syndrome 12.3.3. Gastrointestinal Cancers 12.3.4. Colorectal Cancer 12.3.5. Stomach Cancer 12.3.6. Esophageal Cancer 12.3.7. Pancreatic Cancer 12.4. Market Attractiveness Analysis by Application 13. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User 13.1. Introduction / Key Findings 13.2. Historical Market Size (US$ Million) Analysis by End User, 2017 to 2022 13.3. Current and Future Market Size (US$ Million) Analysis and Forecast by End User, 2023 to 2033 13.3.1. Hospitals and Clinics 13.3.2. Ambulatory Surgical Centers 13.4. Market Attractiveness Analysis by End User 14. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region 14.1. Introduction / Key Findings 14.2. Historical Market Size (US$ Million) and Volume Analysis, by Region, 2017 to 2022 14.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis Forecast by Region, 2023 to 2033 14.3.1. North America 14.3.2. Latin America 14.3.3. Europe 14.3.4. East Asia 14.3.5. South Asia 14.3.6. Oceania 14.3.7. The Middle East & Africa 14.4. Market Attractiveness Analysis by Region 15. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033 15.1. Introduction 15.2. Historical Market Size (US$ Million) and Volume (Units) Analysis by Market Taxonomy, 2017 to 2022 15.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033 15.3.1. By Country 15.3.1.1. USA 15.3.1.2. Canada 15.3.2. By Product 15.3.3. BY Application 15.3.4. By Material 15.3.5. By End User 15.4. Market Attractiveness Analysis 15.4.1. By Country 15.4.2. By Product 15.4.3. By Material 15.4.4. By Application 15.4.5. By End User 15.5. Market Trends 15.6. Key Market Participants - Intensity Mapping 15.7. Drivers and Restraints - Impact Analysis 15.8. Country Level Analysis & Forecast 15.8.1. USA Market Analysis 15.8.1.1. Introduction 15.8.1.2. Market Analysis and Forecast by Market Taxonomy 15.8.1.2.1. By Product 15.8.1.2.2. By Material 15.8.1.2.3. By Application 15.8.1.2.4. By End User 15.8.2. Canada Market Analysis 15.8.2.1. Introduction 15.8.2.2. Market Analysis and Forecast by Market Taxonomy 15.8.2.2.1. By Product 15.8.2.2.2. By Material 15.8.2.2.3. By Application 15.8.2.2.4. By End User 16. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033 16.1. Introduction 16.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022 16.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033 16.3.1. By Country 16.3.1.1. Mexico 16.3.1.2. Brazil 16.3.1.3. Argentina 16.3.1.4. Rest of Latin America 16.3.2. By Product 16.3.3. By Material 16.3.4. By Application 16.3.5. By End User 16.4. Market Attractiveness Analysis 16.4.1. By Country 16.4.2. By Product 16.4.3. By Material 16.4.4. By Application 16.4.5. By End User 16.5. Market Trends 16.6. Key Market Participants - Intensity Mapping 16.7. Drivers and Restraints - Impact Analysis 16.8. Country Level Analysis & Forecast 16.8.1. Mexico Market Analysis 16.8.1.1. Introduction 16.8.1.2. Market Analysis and Forecast by Market Taxonomy 16.8.1.2.1. By Product 16.8.1.2.2. By Material 16.8.1.2.3. By Application 16.8.1.2.4. By End User 16.8.2. Brazil Market Analysis 16.8.2.1. Introduction 16.8.2.2. Market Analysis and Forecast by Market Taxonomy 16.8.2.2.1. By Product 16.8.2.2.2. By Material 16.8.2.2.3. By Application 16.8.2.2.4. By End User 16.8.3. Argentina Market Analysis 16.8.3.1. Introduction 16.8.3.2. Market Analysis and Forecast by Market Taxonomy 16.8.3.2.1. By Product 16.8.3.2.2. By Material 16.8.3.2.3. By Application 16.8.3.2.4. By End User 17. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033 17.1. Introduction 17.2. Historical Market Size (US$ Million) and Volume (Units) Analysis by Market Taxonomy, 2017 to 2022 17.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033 17.3.1. By Country 17.3.1.1. Germany 17.3.1.2. Italy 17.3.1.3. France 17.3.1.4. United Kingdom 17.3.1.5. Spain 17.3.1.6. BENELUX 17.3.1.7. Russia 17.3.1.8. Rest of Europe 17.3.2. By Product 17.3.3. By Material 17.3.4. By Application 17.3.5. By End User 17.4. Market Attractiveness Analysis 17.4.1. By Country 17.4.2. By Product 17.4.3. By Material 17.4.4. By Application 17.4.5. By End User 17.5. Market Trends 17.6. Key Market Participants - Intensity Mapping 17.7. Drivers and Restraints - Impact Analysis 17.8. Country Level Analysis & Forecast 17.8.1. Germany Market Analysis 17.8.1.1. Introduction 17.8.1.2. Market Analysis and Forecast by Market Taxonomy 17.8.1.2.1. By Product 17.8.1.2.2. By Material 17.8.1.2.3. By Application 17.8.1.2.4. By End User 17.8.2. Italy Market Analysis 17.8.2.1. Introduction 17.8.2.2. Market Analysis and Forecast by Market Taxonomy 17.8.2.2.1. By Product 17.8.2.2.2. By Material 17.8.2.2.3. By Application 17.8.2.2.4. By End User 17.8.3. France Market Analysis 17.8.3.1. Introduction 17.8.3.2. Market Analysis and Forecast by Market Taxonomy 17.8.3.2.1. By Product 17.8.3.2.2. By Material 17.8.3.2.3. By Application 17.8.3.2.4. By End User 17.8.4. United Kingdom Market Analysis 17.8.4.1. Introduction 17.8.4.2. Market Analysis and Forecast by Market Taxonomy 17.8.4.2.1. By Product 17.8.4.2.2. By Material 17.8.4.2.3. By Application 17.8.4.2.4. By End User 17.8.5. Spain Market Analysis 17.8.5.1. Introduction 17.8.5.2. Market Analysis and Forecast by Market Taxonomy 17.8.5.2.1. By Product 17.8.5.2.2. By Material 17.8.5.2.3. By Application 17.8.5.2.4. By End User 17.8.6. BENELUX Market Analysis 17.8.6.1. Introduction 17.8.6.2. Market Analysis and Forecast by Market Taxonomy 17.8.6.2.1. By Product 17.8.6.2.2. By Material 17.8.6.2.3. By Application 17.8.6.2.4. By End User 17.8.7. Russia Market Analysis 17.8.7.1. Introduction 17.8.7.2. Market Analysis and Forecast by Market Taxonomy 17.8.7.2.1. By Product 17.8.7.2.2. By Material 17.8.7.2.3. By Application 17.8.7.2.4. By End User 18. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033 18.1. Introduction 18.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022 18.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033 18.3.1. By Country 18.3.1.1. China 18.3.1.2. Japan 18.3.1.3. South Korea 18.3.2. By Product 18.3.3. By Material 18.3.4. By Application 18.3.5. By End User 18.4. Market Attractiveness Analysis 18.4.1. By Country 18.4.2. By Product 18.4.3. By Material 18.4.4. By Application 18.4.5. By End User 18.5. Market Trends 18.6. Key Market Participants - Intensity Mapping 18.7. Drivers and Restraints - Impact Analysis 18.8. Country Level Analysis & Forecast 18.8.1. China Market Analysis 18.8.1.1. Introduction 18.8.1.2. Market Analysis and Forecast by Market Taxonomy 18.8.1.2.1. By Product 18.8.1.2.2. By Material 18.8.1.2.3. By Application 18.8.1.2.4. By End User 18.8.2. Japan Market Analysis 18.8.2.1. Introduction 18.8.2.2. Market Analysis and Forecast by Market Taxonomy 18.8.2.2.1. By Product 18.8.2.2.2. By Material 18.8.2.2.3. By Application 18.8.2.2.4. By End User 18.8.3. South Korea Market Analysis 18.8.3.1. Introduction 18.8.3.2. Market Analysis and Forecast by Market Taxonomy 18.8.3.2.1. By Product 18.8.3.2.2. By Material 18.8.3.2.3. By Application 18.8.3.2.4. By End User 19. South Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033 19.1. Introduction 19.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022 19.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033 19.3.1. By Country 19.3.1.1. India 19.3.1.2. Indonesia 19.3.1.3. Malaysia 19.3.1.4. Thailand 19.3.1.5. Rest of South Asia 19.3.2. By Product 19.3.3. By Material 19.3.4. By Application 19.3.5. By End User 19.4. Market Attractiveness Analysis 19.4.1. By Country 19.4.2. By Product 19.4.3. By Material 19.4.4. By Application 19.4.5. By End User 19.5. Market Trends 19.6. Key Market Participants - Intensity Mapping 19.7. Drivers and Restraints - Impact Analysis 19.8. Country Level Analysis & Forecast 19.8.1. India Market Analysis 19.8.1.1. Introduction 19.8.1.2. Market Analysis and Forecast by Market Taxonomy 19.8.1.2.1. By Product 19.8.1.2.2. By Material 19.8.1.2.3. By Application 19.8.1.2.4. By End User 19.8.2. Indonesia Market Analysis 19.8.2.1. Introduction 19.8.2.2. Market Analysis and Forecast by Market Taxonomy 19.8.2.2.1. By Product 19.8.2.2.2. By Material 19.8.2.2.3. By Application 19.8.2.2.4. By End User 19.8.3. Malaysia Market Analysis 19.8.3.1. Introduction 19.8.3.2. Market Analysis and Forecast by Market Taxonomy 19.8.3.2.1. By Product 19.8.3.2.2. By Material 19.8.3.2.3. By Application 19.8.3.2.4. By End User 19.8.4. Thailand Market Analysis 19.8.4.1. Introduction 19.8.4.2. Market Analysis and Forecast by Market Taxonomy 19.8.4.2.1. By Product 19.8.4.2.2. By Material 19.8.4.2.3. By Application 19.8.4.2.4. By End User 20. Oceania Market 2017 to 2022 and Forecast 2023 to 2033 20.1. Introduction 20.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022 20.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033 20.3.1. By Country 20.3.1.1. Australia 20.3.1.2. New Zealand 20.3.2. By Product 20.3.3. By Material 20.3.4. By Application 20.3.5. By End User 20.4. Market Attractiveness Analysis 20.4.1. By Product 20.4.2. By Material 20.4.3. By Application 20.4.4. By End User 20.5. Market Trends 20.6. Key Market Participants - Intensity Mapping 20.7. Drivers and Restraints - Impact Analysis 20.8. Country Level Analysis & Forecast 20.8.1. Australia Market Analysis 20.8.1.1. Introduction 20.8.1.2. Market Analysis and Forecast by Market Taxonomy 20.8.1.2.1. By Product 20.8.1.2.2. By Material 20.8.1.2.3. By Application 20.8.1.2.4. By End User 20.8.2. New Zealand Market Analysis 20.8.2.1. Introduction 20.8.2.2. Market Analysis and Forecast by Market Taxonomy 20.8.2.2.1. By Product 20.8.2.2.2. By Material 20.8.2.2.3. By Application 20.8.2.2.4. By End User 21. Middle East and Africa (MEA) Market Analysis 2017 to 2022 and Forecast 2023 to 2033 21.1. Introduction 21.2. Historical Market Size (US$ Million) and Volume (Units) Analysis by Market Taxonomy, 2017 to 2022 21.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033 21.3.1. By Country 21.3.1.1. GCC Countries 21.3.1.2. Türkiye 21.3.1.3. North Africa 21.3.1.4. South Africa 21.3.1.5. Rest of Middle East and Africa 21.3.2. By Product 21.3.3. By Material 21.3.4. By Application 21.3.5. By End User 21.4. Market Attractiveness Analysis 21.4.1. By Country 21.4.2. By Product 21.4.3. By Material 21.4.4. By Application 21.4.5. By End User 21.5. Market Trends 21.6. Key Market Participants - Intensity Mapping 21.7. Drivers and Restraints - Impact Analysis 21.8. Country Level Analysis & Forecast 21.8.1. GCC Countries Market Analysis 21.8.1.1. Introduction 21.8.1.2. Market Analysis and Forecast by Market Taxonomy 21.8.1.2.1. By Product 21.8.1.2.2. By Material 21.8.1.2.3. By Application 21.8.1.2.4. By End User 21.8.2. Türkiye Market Analysis 21.8.2.1. Introduction 21.8.2.2. Market Analysis and Forecast by Market Taxonomy 21.8.2.2.1. By Product 21.8.2.2.2. By Material 21.8.2.2.3. By Application 21.8.2.2.4. By End User 21.8.3. South Africa Market Analysis 21.8.3.1. Introduction 21.8.3.2. Market Analysis and Forecast by Market Taxonomy 21.8.3.2.1. By Product 21.8.3.2.2. By Material 21.8.3.2.3. By Application 21.8.3.2.4. By End User 21.8.4. North Africa Market Analysis 21.8.4.1. Introduction 21.8.4.2. Market Analysis and Forecast by Market Taxonomy 21.8.4.2.1. By Product 21.8.4.2.2. By Material 21.8.4.2.3. By Application 21.8.4.2.4. By End User 22. Market Structure Analysis 22.1. Market Analysis by Tier of Companies 22.2. Market Share Analysis of Top Players 22.3. Market Presence Analysis 23. Competition Analysis 23.1. Competition Dashboard 23.2. Competition Benchmarking 23.3. Competition Deep Dive 23.3.1. Boston Scientific Corporation 23.3.1.1. Overview 23.3.1.2. Product Portfolio 23.3.1.3. Sales Footprint 23.3.1.4. Key Financials 23.3.1.5. SWOT Analysis 23.3.1.6. Key Developments 23.3.1.7. Strategy Overview 23.3.1.7.1. Marketing Strategy 23.3.1.7.2. Product Strategy 23.3.1.7.3. Channel Strategy 23.3.2. Hobbs Medical Inc. 23.3.2.1. Overview 23.3.2.2. Product Portfolio 23.3.2.3. Sales Footprint 23.3.2.4. Key Financials 23.3.2.5. SWOT Analysis 23.3.2.6. Key Developments 23.3.2.7. Strategy Overview 23.3.2.7.1. Marketing Strategy 23.3.2.7.2. Product Strategy 23.3.2.7.3. Channel Strategy 23.3.3. Taewoong Medical 23.3.3.1. Overview 23.3.3.2. Product Portfolio 23.3.3.3. Sales Footprint 23.3.3.4. Key Financials 23.3.3.5. SWOT Analysis 23.3.3.6. Key Developments 23.3.3.7. Strategy Overview 23.3.3.7.1. Marketing Strategy 23.3.3.7.2. Product Strategy 23.3.3.7.3. Channel Strategy 23.3.4. Micro-Tech (Nanjing) Co., Ltd. 23.3.4.1. Overview 23.3.4.2. Product Portfolio 23.3.4.3. Sales Footprint 23.3.4.4. Key Financials 23.3.4.5. SWOT Analysis 23.3.4.6. Key Developments 23.3.4.7. Strategy Overview 23.3.4.7.1. Marketing Strategy 23.3.4.7.2. Product Strategy 23.3.4.7.3. Channel Strategy 23.3.5. Olympus Corporation 23.3.5.1. Overview 23.3.5.2. Product Portfolio 23.3.5.3. Sales Footprint 23.3.5.4. Key Financials 23.3.5.5. SWOT Analysis 23.3.5.6. Key Developments 23.3.5.7. Strategy Overview 23.3.5.7.1. Marketing Strategy 23.3.5.7.2. Product Strategy 23.3.5.7.3. Channel Strategy 23.3.6. Merit Medical Systems 23.3.6.1. Overview 23.3.6.2. Product Portfolio 23.3.6.3. Sales Footprint 23.3.6.4. Key Financials 23.3.6.5. SWOT Analysis 23.3.6.6. Key Developments 23.3.6.7. Strategy Overview 23.3.6.7.1. Marketing Strategy 23.3.6.7.2. Product Strategy 23.3.6.7.3. Channel Strategy 23.3.7. Qualimed 23.3.7.1. Overview 23.3.7.2. Product Portfolio 23.3.7.3. Sales Footprint 23.3.7.4. Key Financials 23.3.7.5. SWOT Analysis 23.3.7.6. Key Developments 23.3.7.7. Strategy Overview 23.3.7.7.1. Marketing Strategy 23.3.7.7.2. Product Strategy 23.3.7.7.3. Channel Strategy 23.3.8. Medtronic 23.3.8.1. Overview 23.3.8.2. Product Portfolio 23.3.8.3. Sales Footprint 23.3.8.4. Key Financials 23.3.8.5. SWOT Analysis 23.3.8.6. Key Developments 23.3.8.7. Strategy Overview 23.3.8.7.1. Marketing Strategy 23.3.8.7.2. Product Strategy 23.3.8.7.3. Channel Strategy 23.3.9. Conmed Corporation 23.3.9.1. Overview 23.3.9.2. Product Portfolio 23.3.9.3. Sales Footprint 23.3.9.4. Key Financials 23.3.9.5. SWOT Analysis 23.3.9.6. Key Developments 23.3.9.7. Strategy Overview 23.3.9.7.1. Marketing Strategy 23.3.9.7.2. Product Strategy 23.3.9.7.3. Channel Strategy 23.3.10. Terumo Corporation 23.3.10.1. Overview 23.3.10.2. Product Portfolio 23.3.10.3. Sales Footprint 23.3.10.4. Key Financials 23.3.10.5. SWOT Analysis 23.3.10.6. Key Developments 23.3.10.7. Strategy Overview 23.3.10.7.1. Marketing Strategy 23.3.10.7.2. Product Strategy 23.3.10.7.3. Channel Strategy 23.3.11. Johnson & Johnson Services, Inc. 23.3.11.1. Overview 23.3.11.2. Product Portfolio 23.3.11.3. Sales Footprint 23.3.11.4. Key Financials 23.3.11.5. SWOT Analysis 23.3.11.6. Key Developments 23.3.11.7. Strategy Overview 23.3.11.7.1. Marketing Strategy 23.3.11.7.2. Product Strategy 23.3.11.7.3. Channel Strategy 23.3.12. 3M 23.3.12.1. Overview 23.3.12.2. Product Portfolio 23.3.12.3. Sales Footprint 23.3.12.4. Key Financials 23.3.12.5. SWOT Analysis 23.3.12.6. Key Developments 23.3.12.7. Strategy Overview 23.3.12.7.1. Marketing Strategy 23.3.12.7.2. Product Strategy 23.3.12.7.3. Channel Strategy 23.3.13. Smith & Nephew 23.3.13.1. Overview 23.3.13.2. Product Portfolio 23.3.13.3. Sales Footprint 23.3.13.4. Key Financials 23.3.13.5. SWOT Analysis 23.3.13.6. Key Developments 23.3.13.7. Strategy Overview 23.3.13.7.1. Marketing Strategy 23.3.13.7.2. Product Strategy 23.3.13.7.3. Channel Strategy 23.3.14. Diagmed Healthcare 23.3.14.1. Overview 23.3.14.2. Product Portfolio 23.3.14.3. Sales Footprint 23.3.14.4. Key Financials 23.3.14.5. SWOT Analysis 23.3.14.6. Key Developments 23.3.14.7. Strategy Overview 23.3.14.7.1. Marketing Strategy 23.3.14.7.2. Product Strategy 23.3.14.7.3. Channel Strategy 23.3.15. Medline Industries, Inc. 23.3.15.1. Overview 23.3.15.2. Product Portfolio 23.3.15.3. Sales Footprint 23.3.15.4. Key Financials 23.3.15.5. SWOT Analysis 23.3.15.6. Key Developments 23.3.15.7. Strategy Overview 23.3.15.7.1. Marketing Strategy 23.3.15.7.2. Product Strategy 23.3.15.7.3. Channel Strategy 23.3.16. Baxter 23.3.16.1. Overview 23.3.16.2. Product Portfolio 23.3.16.3. Sales Footprint 23.3.16.4. Key Financials 23.3.16.5. SWOT Analysis 23.3.16.6. Key Developments 23.3.16.7. Strategy Overview 23.3.16.7.1. Marketing Strategy 23.3.16.7.2. Product Strategy 23.3.16.7.3. Channel Strategy 23.3.17. B. Braun Melsungen AG 23.3.17.1. Overview 23.3.17.2. Product Portfolio 23.3.17.3. Sales Footprint 23.3.17.4. Key Financials 23.3.17.5. SWOT Analysis 23.3.17.6. Key Developments 23.3.17.7. Strategy Overview 23.3.17.7.1. Marketing Strategy 23.3.17.7.2. Product Strategy 23.3.17.7.3. Channel Strategy 23.3.18. Danaher Corporation 23.3.18.1. Overview 23.3.18.2. Product Portfolio 23.3.18.3. Sales Footprint 23.3.18.4. Key Financials 23.3.18.5. SWOT Analysis 23.3.18.6. Key Developments 23.3.18.7. Strategy Overview 23.3.18.7.1. Marketing Strategy 23.3.18.7.2. Product Strategy 23.3.18.7.3. Channel Strategy 23.3.19. Cantel Medical Corporation 23.3.19.1. Overview 23.3.19.2. Product Portfolio 23.3.19.3. Sales Footprint 23.3.19.4. Key Financials 23.3.19.5. SWOT Analysis 23.3.19.6. Key Developments 23.3.19.7. Strategy Overview 23.3.19.7.1. Marketing Strategy 23.3.19.7.2. Product Strategy 23.3.19.7.3. Channel Strategy 23.3.20. ConvaTec Inc. 23.3.20.1. Overview 23.3.20.2. Product Portfolio 23.3.20.3. Sales Footprint 23.3.20.4. Key Financials 23.3.20.5. SWOT Analysis 23.3.20.6. Key Developments 23.3.20.7. Strategy Overview 23.3.20.7.1. Marketing Strategy 23.3.20.7.2. Product Strategy 23.3.20.7.3. Channel Strategy 23.3.21. M.C. Johnson Company, Inc. 23.3.21.1. Overview 23.3.21.2. Product Portfolio 23.3.21.3. Sales Footprint 23.3.21.4. Key Financials 23.3.21.5. SWOT Analysis 23.3.21.6. Key Developments 23.3.21.7. Strategy Overview 23.3.21.7.1. Marketing Strategy 23.3.21.7.2. Product Strategy 23.3.21.7.3. Channel Strategy 24. Assumptions and Acronyms Used 25. Research Methodology
Healthcare
May 2018
REP-GB-6715
August 2023
306 pages
Explore Healthcare Insights
View Reports
Gastrointestinal Stent Market
